UA89180C2 - Дроспіренон для гормональної замісної терапії - Google Patents
Дроспіренон для гормональної замісної терапіїInfo
- Publication number
- UA89180C2 UA89180C2 UAA200612100A UAA200612100A UA89180C2 UA 89180 C2 UA89180 C2 UA 89180C2 UA A200612100 A UAA200612100 A UA A200612100A UA A200612100 A UAA200612100 A UA A200612100A UA 89180 C2 UA89180 C2 UA 89180C2
- Authority
- UA
- Ukraine
- Prior art keywords
- drospirenone
- estrogene
- replacement therapy
- hormone replacement
- active component
- Prior art date
Links
- METQSPRSQINEEU-UHFFFAOYSA-N dihydrospirorenone Natural products CC12CCC(C3(CCC(=O)C=C3C3CC33)C)C3C1C1CC1C21CCC(=O)O1 METQSPRSQINEEU-UHFFFAOYSA-N 0.000 title abstract 3
- METQSPRSQINEEU-HXCATZOESA-N drospirenone Chemical compound C([C@]12[C@H]3C[C@H]3[C@H]3[C@H]4[C@@H]([C@]5(CCC(=O)C=C5[C@@H]5C[C@@H]54)C)CC[C@@]31C)CC(=O)O2 METQSPRSQINEEU-HXCATZOESA-N 0.000 title abstract 2
- 229960004845 drospirenone Drugs 0.000 title abstract 2
- 238000002657 hormone replacement therapy Methods 0.000 title abstract 2
- 239000000262 estrogen Substances 0.000 abstract 3
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 abstract 1
- RSEPBGGWRJCQGY-RBRWEJTLSA-N Estradiol valerate Chemical compound C1CC2=CC(O)=CC=C2[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)CCCC)[C@@]1(C)CC2 RSEPBGGWRJCQGY-RBRWEJTLSA-N 0.000 abstract 1
- 101000605827 Homo sapiens Pinin Proteins 0.000 abstract 1
- 102100038374 Pinin Human genes 0.000 abstract 1
- 230000005856 abnormality Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- METQSPRSQINEEU-OLKMEILKSA-N drospirenone Chemical compound C([C@]12[C@H]3C[C@H]3C3C4[C@@H]([C@]5(CCC(=O)C=C5[C@@H]5C[C@@H]54)C)CC[C@@]31C)CC(=O)O2 METQSPRSQINEEU-OLKMEILKSA-N 0.000 abstract 1
- 210000004696 endometrium Anatomy 0.000 abstract 1
- 229960005309 estradiol Drugs 0.000 abstract 1
- 229930182833 estradiol Natural products 0.000 abstract 1
- 229960004766 estradiol valerate Drugs 0.000 abstract 1
- 230000009245 menopause Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00200183 | 2000-01-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA89180C2 true UA89180C2 (uk) | 2010-01-11 |
Family
ID=38170612
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200612100A UA89180C2 (uk) | 2000-01-18 | 2001-01-18 | Дроспіренон для гормональної замісної терапії |
| UA2002086809A UA81388C2 (en) | 2000-01-18 | 2001-01-18 | Pharmaceutical composition comprising estrogen and drospirenone for hormone replacement therapy |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UA2002086809A UA81388C2 (en) | 2000-01-18 | 2001-01-18 | Pharmaceutical composition comprising estrogen and drospirenone for hormone replacement therapy |
Country Status (7)
| Country | Link |
|---|---|
| AR (1) | AR035633A1 (uk) |
| CO (1) | CO5280075A1 (uk) |
| HR (1) | HRP20070360B1 (uk) |
| JO (1) | JO2334B1 (uk) |
| PE (1) | PE20011051A1 (uk) |
| SA (1) | SA01210754B1 (uk) |
| UA (2) | UA89180C2 (uk) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4426601A1 (de) * | 1994-07-27 | 1996-02-01 | Schering Ag | Verwendung eines Kombinationsproduktes enthaltend einen kompetitiven Progesteronantagonisten und ein Gestagen zur Herstellung eines Arzneimittels zur Behandlung der Endometriose oder des Leiomyomata uteri |
| DE19654609A1 (de) * | 1996-12-20 | 1998-06-25 | Schering Ag | Therapeutische Gestagene zur Behandlung von Premenstrual Dysphoric Disorder |
| DE60006692T2 (de) * | 1999-08-31 | 2004-09-23 | Schering Ag | Pharmazeutische kombination von ethinylestradiol und drospirenone als empfängnisverhütendes mittel |
-
2001
- 2001-01-11 JO JO200110A patent/JO2334B1/en active
- 2001-01-15 PE PE2001000035A patent/PE20011051A1/es active IP Right Grant
- 2001-01-17 AR ARP010100199 patent/AR035633A1/es not_active Application Discontinuation
- 2001-01-17 CO CO01003045A patent/CO5280075A1/es not_active Application Discontinuation
- 2001-01-18 UA UAA200612100A patent/UA89180C2/uk unknown
- 2001-01-18 UA UA2002086809A patent/UA81388C2/uk unknown
- 2001-01-18 HR HRP20070360AA patent/HRP20070360B1/hr not_active IP Right Cessation
- 2001-03-21 SA SA01210754A patent/SA01210754B1/ar unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CO5280075A1 (es) | 2003-05-30 |
| JO2334B1 (en) | 2006-06-28 |
| HRP20070360B1 (hr) | 2014-11-21 |
| AR035633A1 (es) | 2004-06-23 |
| UA81388C2 (en) | 2008-01-10 |
| PE20011051A1 (es) | 2001-10-17 |
| SA01210754B1 (ar) | 2007-02-17 |
| HRP20070360A2 (hr) | 2008-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU54602A (sh) | Drospirenon za terapiju zamene hormona | |
| EA200201000A1 (ru) | Гормон-заместительная терапия | |
| IL149448A0 (en) | New topical estrogen-progestogen compositions with a systemic effect | |
| NZ516502A (en) | Administration of non-oral androgenic steroids to women having an elevated level of sex hormone binding globulin (SHBG) | |
| IL122432A (en) | Transdermal patch for preventing ovulation | |
| NZ262657A (en) | Hormone replacement therapy using estrogen and antiprogestin | |
| WO2006053172A3 (en) | The use of estriol and other estranes, estrogens and estrogen receptor active compositions in the treatment of psoriasis and other autoimmune diseases | |
| EP1796725B1 (en) | Treatment or prevention of unscheluded bleeding in women on progestogen containing medication | |
| IL154975A0 (en) | Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases | |
| AU759925B2 (en) | Oral contraceptive preparation having a first phase comprising progestin/estrogen and a second phase comprising progestin | |
| UA89180C2 (uk) | Дроспіренон для гормональної замісної терапії | |
| CA2261748A1 (en) | Biphasic contraceptive method and kit comprising a combination of a progestin and estrogen | |
| HK1048600A1 (zh) | 基於促孕剂和雌激素的避孕药及其制法 | |
| CA2248841A1 (en) | Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy | |
| WO2003084521A3 (en) | Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy | |
| HRP20020666A8 (en) | Drospirenone for hormone replacement therapy | |
| EA007840B1 (ru) | Мезопрогестины (модуляторы рецептора прогестерона) в качестве компонента композиций для заместительной гормональной терапии (згт) | |
| Oelkers | The renin–aldosterone system and drospirenone | |
| UY26539A1 (es) | Drospirenona para terapia de reemplazo de hormonas. | |
| WO2025109167A9 (en) | Combined oral contraceptive with a favorable blood pressure profile | |
| YU16403A (sh) | 4-halogenovani 17-metilen steroidi, postupak njihove proizvodnje i farmaceutski sastavi koji sadrže ova jedinjenja | |
| Hammar et al. | Are there any alternatives to hormone replacement therapy? | |
| YU30103A (sh) | Upotreba antiprogestina za profilaksu i lečenje hormonski zavisnih bolesti | |
| CA2388237A1 (en) | Treatment of osteoporosis | |
| AU5942700A (en) | Sequential estrogen/progestrone antagonist combination for hormone replacement theapy |